These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Biological maturation and beta-adrenergic effectors: pre- and postnatal development of the adenylate cyclase system in the rabbit heart. Schumacher WA; Sheppard JR; Mirkin BL J Pharmacol Exp Ther; 1982 Dec; 223(3):587-93. PubMed ID: 6292391 [TBL] [Abstract][Full Text] [Related]
23. [Role of guanyl nucleotides in regulation of activity of heart adenylate cyclase by chloride ions]. Tkachuk VA; Avdonin PV; Panchenko MP Biokhimiia; 1981 Feb; 46(2):333-41. PubMed ID: 7248388 [TBL] [Abstract][Full Text] [Related]
24. Examination of interspecies differences in renal and skeletal receptor binding and adenylate cyclase stimulation with human calcitonin. Goltzman D Endocrinology; 1980 Feb; 106(2):510-8. PubMed ID: 6243538 [No Abstract] [Full Text] [Related]
25. The glucagon receptor from liver can be functionally fused to caudate nucleus adenylate cyclase. Tolkovsky AM; Martin BR FEBS Lett; 1982 Dec; 150(2):337-42. PubMed ID: 6297980 [No Abstract] [Full Text] [Related]
26. Adenosine receptors in fat cells. Identification by (-)-N6-[3H]phenylisopropyladenosine binding. Trost T; Schwabe U Mol Pharmacol; 1981 Mar; 19(2):228-35. PubMed ID: 6262616 [No Abstract] [Full Text] [Related]
27. Adenosine receptors in smooth muscle and other tissues. Baer HP; Paton DM Adv Cyclic Nucleotide Res; 1978; 9():315-25. PubMed ID: 208381 [No Abstract] [Full Text] [Related]
28. Receptor-mediated stimulation and inhibition of adenylate cyclases: the fat cell as a model system. Londos C; Cooper DM; Rodbell M Adv Cyclic Nucleotide Res; 1981; 14():163-71. PubMed ID: 6269378 [No Abstract] [Full Text] [Related]
30. Theoretical simulation of a model describing hormone receptor--adenylate cyclase coupling. Swillens S Adv Cyclic Nucleotide Res; 1981; 14():121-5. PubMed ID: 6269374 [TBL] [Abstract][Full Text] [Related]
31. Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5'-guanylylimidodiphosphate or N-ethylmaleimide. Yeung SM; Green RD J Biol Chem; 1983 Feb; 258(4):2334-9. PubMed ID: 6296141 [No Abstract] [Full Text] [Related]
32. Characteristics of the enzymatic hydrolysis of 5'-adenylylimidodiphosphate: implications for the study of adenylate cyclase. Johnson RA; Welden J Arch Biochem Biophys; 1977 Sep; 183(1):216-27. PubMed ID: 20846 [No Abstract] [Full Text] [Related]
33. Differential effects of guanine nucleotides on the first step of VIP and glucagon action in membranes from liver cells. Amiranoff B; Laburthe M; Rosselin G Biochem Biophys Res Commun; 1980 Sep; 96(1):463-8. PubMed ID: 6254514 [No Abstract] [Full Text] [Related]
34. Desensitization to parathyroid hormone in the isolated perfused canine kidney: reversal of altered receptor-adenylate cyclase system by guanosine triphosphate in vitro. Tamayo J; Bellorin-Font E; Sicard G; Anderson C; Martin KJ Endocrinology; 1982 Oct; 111(4):1311-7. PubMed ID: 6288355 [No Abstract] [Full Text] [Related]
36. Adenosine, adenylate cyclase, and transmitter release. Phillis JW; Barraco RA Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():243-57. PubMed ID: 2860780 [No Abstract] [Full Text] [Related]
37. The coupling of hormone receptors and adenylate cyclase. Rodbell M Ups J Med Sci; 1977; 82(2):106. PubMed ID: 20078303 [No Abstract] [Full Text] [Related]
39. Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: evaluation of structure-activity relationships. Wu PH; Phillis JW; Nye MJ Life Sci; 1982 Dec; 31(25):2857-67. PubMed ID: 6298531 [No Abstract] [Full Text] [Related]
40. On the presence of receptors for ACTH neuropeptides in the brain. Witter A Adv Biochem Psychopharmacol; 1980; 21():407-14. PubMed ID: 6246752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]